US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
HU218673B
(hu)
*
|
1993-10-07 |
2000-10-28 |
Euroceltique S.A. |
Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
AU718160B2
(en)
*
|
1995-06-09 |
2000-04-06 |
R.P. Scherer Corporation |
Soft gelatin capsules containing particulate material
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5733578A
(en)
*
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US5939356A
(en)
*
|
1996-06-21 |
1999-08-17 |
Southwest Research Institute |
Controlled release coated agricultural products
|
AU4219497A
(en)
*
|
1996-09-13 |
1998-04-02 |
Shionogi & Co., Ltd. |
Sustained-release preparation utilizing thermal change and process for the production thereof
|
US5807580A
(en)
*
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
US6180128B1
(en)
*
|
1997-01-27 |
2001-01-30 |
C-Cure Corp. |
Non-carcinogenic substitute for play sand
|
WO1999001111A1
(en)
|
1997-07-02 |
1999-01-14 |
Euro-Celtique, S.A. |
Stabilized sustained release tramadol formulations
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
DE69841422D1
(de)
|
1997-10-15 |
2010-02-11 |
Univ South Florida |
Beschichtung von partikelmaterial mittels superkritischer flüssigkeit
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
US6485748B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
CN1234362C
(zh)
|
1997-12-22 |
2006-01-04 |
欧罗赛铁克股份有限公司 |
阿片样激动剂/阿片样拮抗剂组合物
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5976507A
(en)
*
|
1998-06-04 |
1999-11-02 |
Colgate Palmolive Company |
Dentrifice composition containing encapsulated reactive ingredients
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19901686A1
(de)
*
|
1999-01-18 |
2000-07-20 |
Gruenenthal Gmbh |
Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
JP2003509439A
(ja)
*
|
1999-09-14 |
2003-03-11 |
スミスクライン・ビーチャム・コーポレイション |
水性コーティングされたビーズレットの製法
|
CN1407884B
(zh)
|
1999-10-29 |
2012-06-20 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
EP2092936B1
(en)
|
2000-02-08 |
2013-03-20 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
EP1255547B1
(en)
|
2000-02-08 |
2008-08-20 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
GB0007419D0
(en)
†
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
SE0001151D0
(sv)
*
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method for producing a controlled-release composition
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6663686B1
(en)
*
|
2000-06-27 |
2003-12-16 |
Agrium, Inc. |
Controlled release fertilizer and method for production thereof
|
WO2002036099A1
(en)
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
BR0115585A
(pt)
|
2000-11-28 |
2005-12-13 |
Fmc Corp |
Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
|
US6486248B2
(en)
|
2001-01-08 |
2002-11-26 |
Milliken & Company |
Liquid colorant and method
|
US6878309B2
(en)
*
|
2001-02-12 |
2005-04-12 |
Dober Chemical Corp. |
Controlled release cooling additive composition
|
US6946146B2
(en)
*
|
2001-04-18 |
2005-09-20 |
Nostrum Pharmaceuticals Inc. |
Coating for a sustained release pharmaceutical composition
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
ATE493130T1
(de)
|
2001-05-11 |
2011-01-15 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
EP1416842B1
(en)
|
2001-07-18 |
2008-12-31 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
MXPA04001210A
(es)
|
2001-08-06 |
2004-07-08 |
Euro Celtique Sa |
Formulaciones de agonista opioide con antagonista liberable y aislado.
|
US20030068375A1
(en)
*
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
WO2003020242A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Srl Technologies, Inc. |
Sustained release preparations
|
JP4925526B2
(ja)
*
|
2001-09-10 |
2012-04-25 |
旭化成ケミカルズ株式会社 |
薬物の混合方法
|
AR036797A1
(es)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
|
IL146462A
(en)
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
FR2832632B1
(fr)
|
2001-11-26 |
2004-04-23 |
Mane Fils V |
Capsule a solubilisation et liberation du contenu rapides
|
US20030118647A1
(en)
*
|
2001-12-04 |
2003-06-26 |
Pawan Seth |
Extended release tablet of metformin
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
IL163846A0
(en)
|
2002-03-01 |
2005-12-18 |
Univ South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
LT2425821T
(lt)
*
|
2002-04-05 |
2017-07-25 |
Euro-Celtique S.A. |
Farmacinis preparatas, turintis oksikodono ir naloksono
|
US6958161B2
(en)
*
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
EP1515703A1
(en)
|
2002-06-21 |
2005-03-23 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
EP1526843A1
(en)
*
|
2002-07-25 |
2005-05-04 |
Pharmacia Corporation |
Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
|
US8679533B2
(en)
*
|
2002-07-25 |
2014-03-25 |
Pharmacia Corporation |
Pramipexole once-daily dosage form
|
AR040680A1
(es)
*
|
2002-07-25 |
2005-04-13 |
Pharmacia Corp |
Composicion de tabletas de liberacion sostenida
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
US20040016276A1
(en)
*
|
2002-07-26 |
2004-01-29 |
Wynnyk Nick P. |
Controlled release fertilizer having improved mechanical handling durability and method for production thereof
|
KR20050086409A
(ko)
|
2002-08-15 |
2005-08-30 |
유로-셀티크 소시에떼 아노뉨 |
약학 조성물
|
US20040043064A1
(en)
*
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
AU2003267231A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
WO2004026283A1
(en)
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Sequestering subunit and related compositions and metohds
|
ES2206047B1
(es)
*
|
2002-10-22 |
2005-08-01 |
Universidad De Granada |
Sintesis de un transportador de morfina para formas farmaceuticas liquidas orales de accion controlada.
|
US20060148877A1
(en)
*
|
2002-11-26 |
2006-07-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
EP1575569B1
(en)
|
2002-12-13 |
2010-09-29 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
WO2004093819A2
(en)
|
2003-04-21 |
2004-11-04 |
Euro-Celtique, S.A. |
Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
|
WO2004093883A2
(en)
|
2003-04-23 |
2004-11-04 |
Ferring B.V. |
Sachet for a pharmaceutical composition
|
GB2402679A
(en)
*
|
2003-06-10 |
2004-12-15 |
Reckitt Benckiser Nv |
Automatic washing machine detergent dispensing device
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
FR2859729B1
(fr)
*
|
2003-09-12 |
2006-02-24 |
Roquette Freres |
Dispersions aqueuses d'au moins un polymere biodegradable
|
EP1663229B1
(en)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
DE602004005076T2
(de)
*
|
2003-12-09 |
2007-11-15 |
Euro-Celtique S.A. |
Co-extrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
|
US8883204B2
(en)
*
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
EP1547601A1
(en)
|
2003-12-23 |
2005-06-29 |
Ferring B.V. |
Coating method
|
RS50817B
(sr)
*
|
2004-03-30 |
2010-08-31 |
Euro-Celtique S.A. |
Dozni oblik otporan na promene koji sadrži adsorbenti i sredstvo sa suprotnim dejstvom
|
TWI365880B
(en)
|
2004-03-30 |
2012-06-11 |
Euro Celtique Sa |
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
MX2007001706A
(es)
*
|
2004-08-13 |
2007-04-12 |
Boehringer Ingelheim Int |
Formulacion de comprimidos de liberacion extendida que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para su fabricacion y su uso.
|
UA88477C2
(ru)
*
|
2004-08-13 |
2009-10-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
CA2578540A1
(en)
|
2004-09-01 |
2006-03-16 |
Euro-Celtique S.A. |
Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
GB0427455D0
(en)
*
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
MX2007009088A
(es)
*
|
2005-01-27 |
2007-09-13 |
Alembic Ltd |
Formulacion de liberacion extendida de levetiracetam.
|
JP5704789B2
(ja)
*
|
2005-01-28 |
2015-04-22 |
ユーロ−セルティーク エス.エイ. |
耐アルコール性剤形
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1754471A1
(de)
|
2005-08-18 |
2007-02-21 |
ORAMON-Arzneimittel GmbH & Co. KG |
Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
SI3095447T1
(sl)
|
2006-02-03 |
2022-02-28 |
Opko Renal, Llc |
Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
|
JP2009526096A
(ja)
*
|
2006-02-07 |
2009-07-16 |
エフ エム シー コーポレーション |
徐放性被覆をつくるためのコーティング方法
|
WO2007090883A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Extended release formulation
|
CA2641665A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Modified release formulation
|
FR2897267A1
(fr)
*
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US8158156B2
(en)
|
2006-06-19 |
2012-04-17 |
Alpharma Pharmaceuticals, Llc |
Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
|
JP5563296B2
(ja)
|
2006-06-21 |
2014-07-30 |
プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー |
二次性副甲状腺機能亢進症の治療及び予防方法
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
EP2124564A1
(en)
*
|
2007-01-10 |
2009-12-02 |
Bayer CropScience AG |
Insecticidal fertilizer mixtures
|
US7879747B2
(en)
|
2007-03-30 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Elastic laminates having fragrance releasing properties and methods of making the same
|
CN101668532B
(zh)
|
2007-04-25 |
2014-08-20 |
赛特克罗公司 |
治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
|
CA2683514C
(en)
|
2007-04-25 |
2019-07-09 |
Proventiv Therapeutics, Llc |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
CA2943032C
(en)
|
2007-04-25 |
2019-05-07 |
Cytochroma Inc. |
Oral controlled release compositions comprising vitamin d compound and waxy carrier
|
US8007707B1
(en)
|
2007-05-15 |
2011-08-30 |
Fresh Products, Inc. |
Method of manufacture air freshening article
|
EP2200613B1
(en)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
PL2057984T3
(pl)
*
|
2007-11-09 |
2010-05-31 |
Acino Pharma Ag |
Tabletki z hydromorfonem o przedłużonym uwalnianiu
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
US8404260B2
(en)
*
|
2008-04-02 |
2013-03-26 |
Bayer Cropscience Lp |
Synergistic pesticide compositions
|
CA2714996C
(en)
|
2008-04-02 |
2020-04-07 |
Cytochroma Inc. |
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
DE102008021473A1
(de)
*
|
2008-04-29 |
2009-11-12 |
Heraeus Kulzer Gmbh |
Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
|
US7883638B2
(en)
|
2008-05-27 |
2011-02-08 |
Dober Chemical Corporation |
Controlled release cooling additive compositions
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
WO2010053337A2
(ko)
*
|
2008-11-10 |
2010-05-14 |
(주)아모레퍼시픽 |
서방성 미립자 및 이의 제조방법
|
DK3045043T3
(da)
|
2009-02-26 |
2020-08-03 |
Relmada Therapeutics Inc |
Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
|
US9271940B2
(en)
|
2009-03-10 |
2016-03-01 |
Purdue Pharma L.P. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011123476A1
(en)
|
2010-03-29 |
2011-10-06 |
Cytochroma Inc. |
Methods and compositions for reducing parathyroid levels
|
US20120090366A1
(en)
*
|
2010-04-16 |
2012-04-19 |
Taylor Pursell |
Controlled release fertilizer with biopolymer coating and process for making same
|
JP2013526523A
(ja)
|
2010-05-11 |
2013-06-24 |
シマ ラブス インク. |
メトプロロールを含むアルコール耐性持続放出性経口剤形
|
WO2012030927A2
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Modified-release dosage forms of 5-ht2c agonists useful for weight management
|
EP2654734A2
(en)
|
2010-12-22 |
2013-10-30 |
Purdue Pharma LP |
Encased tamper resistant controlled release dosage forms
|
BR112013015939A2
(pt)
|
2010-12-23 |
2020-08-04 |
Purdue Pharma L.P. |
formas farmacêuticas orais sólidas resistentes à adulteração
|
DK2714015T3
(en)
*
|
2011-06-01 |
2017-06-19 |
Fmc Corp |
Fixed controlled release dosage forms
|
US9243394B2
(en)
|
2011-09-20 |
2016-01-26 |
Fresh Products, Inc. |
Replaceable restroom urinal assemblies, including urinal screens
|
KR101643219B1
(ko)
*
|
2011-10-06 |
2016-07-27 |
노파르티스 아게 |
40-o-(2-히드록시)에틸-라파마이신을 포함하는 제약 조성물
|
WO2013126552A1
(en)
|
2012-02-21 |
2013-08-29 |
Auburn University |
Buprenorphine nanoparticle composition and methods thereof
|
CA2868413C
(en)
|
2012-04-17 |
2021-07-20 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
MX362838B
(es)
|
2012-07-12 |
2019-02-19 |
SpecGx LLC |
Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.
|
SG11201407986QA
(en)
|
2012-07-16 |
2015-02-27 |
Rhodes Technologies |
Process for improved opioid synthesis
|
AR092858A1
(es)
|
2012-07-16 |
2015-05-06 |
Rhodes Tech |
Procedimiento para una sintesis mejorada de opioide
|
KR101840526B1
(ko)
|
2013-02-05 |
2018-03-20 |
퍼듀 퍼머 엘피 |
내변조성 제약 제제
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2015011189A1
(en)
|
2013-07-23 |
2015-01-29 |
Euro-Celtique S.A. |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
GB2517000B
(en)
|
2013-08-02 |
2018-05-09 |
Johnson Matthey Plc |
Process for the synthesis of oxymorphone alkaloid and oxymorphone salts
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
WO2015107471A1
(en)
|
2014-01-15 |
2015-07-23 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
ES2672795T3
(es)
|
2014-01-15 |
2018-06-18 |
Rhodes Technologies |
Proceso para la síntesis mejorada de oximorfona
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
EP2937096B1
(en)
|
2014-04-23 |
2019-08-21 |
Julius-Maximilians-Universität Würzburg |
Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
|
US10258583B2
(en)
|
2014-05-01 |
2019-04-16 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of guanfacine
|
US20180104197A9
(en)
*
|
2014-05-01 |
2018-04-19 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
EP3137060B2
(en)
|
2014-05-01 |
2023-12-20 |
Sun Pharmaceutical Industries Ltd |
Extended release suspension compositions
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
US10285908B2
(en)
|
2014-07-30 |
2019-05-14 |
Sun Pharmaceutical Industries Ltd |
Dual-chamber pack
|
PE20170392A1
(es)
|
2014-08-07 |
2017-04-07 |
Opko Ireland Global Holdings Ltd |
Terapia adjuntiva con 25-hidroxi vitamina d
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
USD778411S1
(en)
|
2014-11-05 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
DE202015102279U1
(de)
|
2014-11-05 |
2015-08-14 |
Fresh Products, Inc. |
Urinalsieb
|
USD778412S1
(en)
|
2014-11-10 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
US10576076B2
(en)
|
2015-05-20 |
2020-03-03 |
Novartis Ag |
Pharmaceutical combination of everolimus with dactolisib
|
WO2017015309A1
(en)
|
2015-07-22 |
2017-01-26 |
John Hsu |
Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
|
CR20180510A
(es)
|
2016-03-28 |
2019-05-15 |
Opko Ireland Global Holdings Ltd |
Método de tratamiento con vitamina d
|
US10369078B2
(en)
|
2016-05-02 |
2019-08-06 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for pharmaceutical compositions
|
US10238803B2
(en)
|
2016-05-02 |
2019-03-26 |
Sun Pharmaceutical Industries Limited |
Drug delivery device for pharmaceutical compositions
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
US10441584B2
(en)
|
2016-11-23 |
2019-10-15 |
Novartis Ag |
Methods of enhancing immune response
|
MX2020006545A
(es)
|
2017-12-20 |
2020-09-14 |
Fresh Prod Inc |
Pantallas para mingitorios.
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
EP3594194A1
(en)
|
2018-07-12 |
2020-01-15 |
Casale Sa |
Urea granulation process
|
CN108958335B
(zh)
*
|
2018-07-27 |
2021-08-24 |
中国兵器工业第五九研究所 |
一种气候模块化数控贮存试验系统
|
USD925009S1
(en)
|
2018-10-25 |
2021-07-13 |
Fresh Products, Inc. |
Urinal screen
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
EP3965733A4
(en)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
|
BR112022020353A2
(pt)
*
|
2020-04-13 |
2022-11-22 |
Aki Inc |
Palheta de colarinho difusora descartável, e, artigo
|
MX2023008983A
(es)
|
2021-02-02 |
2023-10-18 |
Dupont Nutrition Usa Inc |
Una composicion de gel acuoso que comprende una etilcelulosa.
|
CN115844854A
(zh)
*
|
2022-10-26 |
2023-03-28 |
沈阳药科大学 |
一种微囊型自悬浮茶碱缓释颗粒及其制备方法
|